awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51246665-312A4F55-C2CA-4EB8-95A9-D30558D1D404
Q51246665-312A4F55-C2CA-4EB8-95A9-D30558D1D404
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51246665-312A4F55-C2CA-4EB8-95A9-D30558D1D404
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study.
P2860
Q51246665-312A4F55-C2CA-4EB8-95A9-D30558D1D404
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51246665-312A4F55-C2CA-4EB8-95A9-D30558D1D404
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41782419a269b9f51d39ba4bfb91add6ad4b1f46
P2860
Dapagliflozin as monotherapy or combination therapy in Japanese patients with type 2 diabetes: an open-label study.